Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents

被引：0
|
作者：
M N Saha
Y Chen
M-H Chen
G Chen
H Chang
机构：
[1] Toronto General Research Institute,Division of Molecular and Cellular Biology
[2] University of Toronto,Department of Laboratory Medicine & Pathobiology
[3] The First Affiliated Hospital of Nanchang University,Department of Hematology
[4] University Health Network,Department of Laboratory Hematology and Medical Oncology
来源：
British Journal of Cancer | 2014年 / 110卷
关键词：
myeloma; MIRA; p53; apoptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2224 / 2231
页数：7
相关论文
共 50 条
  • [1] Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents
    Saha, M. N.
    Chen, Y.
    Chen, M-H
    Chen, G.
    Chang, H.
    [J]. BRITISH JOURNAL OF CANCER, 2014, 110 (09) : 2224 - 2231
  • [2] Anti-myeloma activity of pamidronate in vivo
    Dhodapkar, MV
    Singh, J
    Mehta, J
    Fassas, A
    Desikan, KR
    Perlman, M
    Munshi, NC
    Barlogie, B
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (02) : 530 - 532
  • [3] NOVEL MARINE COMPOUNDS WITH ANTI-MYELOMA ACTIVITY IN VITRO AND IN VIVO
    Steiner, N.
    Untergasser, G.
    Kern, J.
    Joehrer, K.
    Seeber, A.
    Aracil, M.
    Willenbacher, W.
    Gastl, G.
    Gunsilius, E.
    [J]. HAEMATOLOGICA, 2014, 99 : 639 - 639
  • [4] Novel anti-myeloma agents and angiogenesis
    Anargyrou, Konstantinos
    Dimopoulos, Meletios-Athanassios
    Sezer, Orhan
    Terpos, Evangelos
    [J]. LEUKEMIA & LYMPHOMA, 2008, 49 (04) : 677 - 689
  • [5] The IAP antagonist birinapant potentiates bortezomib anti-myeloma activity in vitro and in vivo
    Liang Zhou
    Yu Zhang
    Yun Leng
    Yun Dai
    Maciej Kmieciak
    Lora Kramer
    Kanika Sharma
    Yan Wang
    William Craun
    Steven Grant
    [J]. Journal of Hematology & Oncology, 12
  • [6] Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo
    Victoria Barbado, M.
    Medrano, Mayte
    Caballero-Velazquez, Teresa
    Alvarez-Laderas, Isabel
    Ignacio Sanchez-Abarca, Luis
    Garcia-Guerrero, Estefania
    Martin-Sanchez, Jesus
    Valle Rosado, Ivan
    Ignacio Piruat, Jose
    Gonzalez-Naranjo, Pedro
    Eugenia Campillo, Nuria
    Antonio Paez, Juan
    Antonio Perez-Simon, Jose
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (03) : 674 - 685
  • [7] The IAP antagonist birinapant potentiates bortezomib anti-myeloma activity in vitro and in vivo
    Zhou, Liang
    Zhang, Yu
    Leng, Yun
    Dai, Yun
    Kmieciak, Maciej
    Kramer, Lora
    Sharma, Kanika
    Wang, Yan
    Craun, William
    Grant, Steven
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
  • [8] Avicins: A novel class of anti-myeloma agents
    Negri, J.
    Mitsiades, N.
    McMullan, C. J.
    Hayden, P.
    McMillin, D.
    Klippel, S.
    Tesmenitsky, Y.
    Haridas, V.
    Munshi, N.
    Richardson, P.
    Gutterman, J.
    Anderson, K. C.
    Mitsiades, C. S.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 144 - 144
  • [9] Modulation of cereblon levels by anti-myeloma agents
    Diaz-Rodriguez, Elena
    Pandiella, Atanasio
    [J]. LEUKEMIA & LYMPHOMA, 2016, 57 (01) : 167 - 176
  • [10] A Deptor Inhibitor Induces Its Degradation with Resulting Anti-Myeloma Cytotoxicity in Vitro and In Vivo
    Vega, Mario I.
    Shi, Yijiang
    Frost, Patrick
    Huerta-Yepez, Sara
    Lichtenstein, Alan
    [J]. BLOOD, 2019, 134
12345